Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We're https://financefeeds.com/superstate-registers-with-sec/